Johan Beetens

1.0k total citations
39 papers, 829 citations indexed

About

Johan Beetens is a scholar working on Biochemistry, Pharmacology and Physiology. According to data from OpenAlex, Johan Beetens has authored 39 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biochemistry, 11 papers in Pharmacology and 9 papers in Physiology. Recurrent topics in Johan Beetens's work include Eicosanoids and Hypertension Pharmacology (12 papers), Inflammatory mediators and NSAID effects (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Johan Beetens is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (12 papers), Inflammatory mediators and NSAID effects (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Johan Beetens collaborates with scholars based in Belgium, Germany and Austria. Johan Beetens's co-authors include Fred De Clerck, Arnold G. Herman, M C Coene, Paul A. J. Janssen, Yves Somers, W. Loots, Didier de Chaffoy de Courcelles, Eddy Freyne, Hidde Bult and A. Verheyen and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Annals of the Rheumatic Diseases.

In The Last Decade

Johan Beetens

38 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Beetens Belgium 17 221 182 163 159 114 39 829
Yoshimi Imura Japan 16 338 1.5× 117 0.6× 246 1.5× 133 0.8× 78 0.7× 31 1.0k
J.E. Tateson United Kingdom 11 339 1.5× 379 2.1× 193 1.2× 263 1.7× 163 1.4× 17 1.1k
Stefanie Oberle Germany 13 321 1.5× 106 0.6× 84 0.5× 203 1.3× 107 0.9× 14 702
Robert B. Wallis United Kingdom 18 200 0.9× 148 0.8× 233 1.4× 61 0.4× 79 0.7× 46 794
Haruhisa Otani Japan 18 460 2.1× 120 0.7× 110 0.7× 158 1.0× 109 1.0× 46 1.5k
Arie Derksen United States 13 333 1.5× 148 0.8× 84 0.5× 92 0.6× 171 1.5× 17 823
Howard W. Mueller United States 11 412 1.9× 60 0.3× 62 0.4× 156 1.0× 123 1.1× 20 806
Giovanna Santini Italy 12 265 1.2× 419 2.3× 139 0.9× 91 0.6× 146 1.3× 18 884
Andreina Poggi Italy 17 446 2.0× 150 0.8× 91 0.6× 90 0.6× 19 0.2× 32 1.2k
Veronica Fitzgerald United States 15 602 2.7× 72 0.4× 64 0.4× 156 1.0× 263 2.3× 23 1.1k

Countries citing papers authored by Johan Beetens

Since Specialization
Citations

This map shows the geographic impact of Johan Beetens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Beetens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Beetens more than expected).

Fields of papers citing papers by Johan Beetens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Beetens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Beetens. The network helps show where Johan Beetens may publish in the future.

Co-authorship network of co-authors of Johan Beetens

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Beetens. A scholar is included among the top collaborators of Johan Beetens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Beetens. Johan Beetens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thaçi, Diamant, Dave Singh, Paul Passier, et al.. (2022). Phase 1 and 2 Randomized Clinical Studies Determine Lack of Efficacy for Anti-IL-17C Antibody MOR106 in Moderate–Severe Atopic Dermatitis. Journal of Clinical Medicine. 11(23). 7244–7244. 10 indexed citations
2.
Namour, Florence, et al.. (2016). Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects. British Journal of Clinical Pharmacology. 82(1). 139–148. 47 indexed citations
3.
Vanhoutte, Frédéric, Sonia Dupont, Roland Blanqué, et al.. (2015). P612. Human safety, pharmacokinetics and pharmacodynamics of the GPR84 antagonist GLPG1205, a potential new approach to treat IBD.. Journal of Crohn s and Colitis. 9(suppl 1). S387–S387. 3 indexed citations
4.
Westhovens, René, Filip De Keyser, Е. Л. Насонов, et al.. (2012). Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial. Annals of the Rheumatic Diseases. 72(5). 741–744. 18 indexed citations
5.
6.
Westhovens, René, Filip De Keyser, Е. Л. Насонов, et al.. (2011). A twelve-week exploratory phase II trial of GLPG0259 versus placebo in patients with active rheumatoid arthritis and inadequate response to methotrexate. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
7.
Baert, Bram, Eric Deconinck, Mireille Van Gele, et al.. (2007). Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds. Bioorganic & Medicinal Chemistry. 15(22). 6943–6955. 44 indexed citations
8.
Weber, Claudia E.M., et al.. (1992). Gas chromatographic—mass spectrometric determination of 11-dehydrothromboxane B2 in human urine. Journal of Chromatography B Biomedical Sciences and Applications. 577(1). 1–7. 3 indexed citations
9.
Weber, Christian, Johan Beetens, F. Tegtmeier, et al.. (1992). Ridogrel Inhibits Systemic and Renal Formation of Thromboxane A2 and Antagonizes Platelet Thromboxane A2/Prostaglandin Endoperoxide Receptors upon Chronic Administration to Man. Thrombosis and Haemostasis. 68(2). 214–220. 4 indexed citations
10.
Weber, Christian, et al.. (1991). Production of thromboxane and prostaglandins in human blood in the presence of thromboxane synthase inhibitors. Blood Coagulation & Fibrinolysis. 2(1). 7–16. 38 indexed citations
11.
Weber, Claudia E.M., et al.. (1991). Determination of 6-keto-PGF1α, 2,3-dinor-6-keto-PGF1α, thromboxane B2, 2,3-dinor-thromboxane B2, PGE2, PGD2 and PGF2α in human urine by gas chromatography—negative ion chemical ionization mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 562(1-2). 599–611. 17 indexed citations
12.
Clerck, Fred De, et al.. (1990). Arachidonic acid metabolites, ADP and thrombin modulate occlusive thrombus formation over extensive arterial injury in the rat. Blood Coagulation & Fibrinolysis. 1(3). 247–258. 10 indexed citations
13.
Clerck, Fred De, W. Loots, Yves Somers, et al.. (1990). 5‐Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in catsin vivo. British Journal of Pharmacology. 99(4). 631–636. 10 indexed citations
14.
Nijkamp, Frans P., Gert Folkerts, Johan Beetens, & Fred De Clerck. (1989). Suppression of PAF-induced bronchoconstriction in the guinea-pig by oxatomide: mechanism of action. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(1). 111–118. 6 indexed citations
15.
Clerck, Fred De, Johan Beetens, Didier de Chaffoy de Courcelles, Eddy Freyne, & Paul A. J. Janssen. (1989). R 68 070: Thromboxane A2 Synthetase Inhibition and Thromboxane A2/Prostaglandin Endoperoxide Receptor Blockade Combined in One Molecule - I. Biochemical Profile In Vitro. Thrombosis and Haemostasis. 61(1). 35–42. 86 indexed citations
16.
Clerck, Fred De, Johan Beetens, A. Van de Water, Els Vercammen, & Paul A. J. Janssen. (1989). R 68 070: Thromboxane A2 Synthetase Inhibition and Thromboxane A2/Prostaglandin Endoperoxide Receptor Blockade Combined in One Molecule - II. Pharmacological Effects In Vivo and Ex Vivo. Thrombosis and Haemostasis. 61(1). 43–49. 69 indexed citations
17.
Rampart, M, et al.. (1986). Complement-dependent stimulation of prostacyclin biosynthesis: inhibition by rosmarinic acid. Biochemical Pharmacology. 35(8). 1397–1400. 33 indexed citations
18.
Clerck, Fred De, et al.. (1985). Platelet-mediated vascular permeability in the rat: A predominant role for 5-hydroxytryptamine. Thrombosis Research. 38(4). 321–339. 30 indexed citations
19.
Beetens, Johan, et al.. (1982). Production of 6-Oxo-PGF1 alpha by aorta rings in the presence of ascorbic acid.. PubMed. 256(1). 151–2. 6 indexed citations
20.
Beetens, Johan, et al.. (1979). Low doses of prostaglandin F2α (PGF2α) stimulate prostacyclin (PGI2) production in the mesenteric circulation of the pig. Prostaglandins and Medicine. 3(2). 95–96. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshimi Imura Breakdown of academic impact, for papers by J.E. Tateson Breakdown of academic impact, for papers by Stefanie Oberle Breakdown of academic impact, for papers by Robert B. Wallis Breakdown of academic impact, for papers by Haruhisa Otani Breakdown of academic impact, for papers by Arie Derksen Breakdown of academic impact, for papers by Howard W. Mueller Breakdown of academic impact, for papers by Giovanna Santini Breakdown of academic impact, for papers by Andreina Poggi Breakdown of academic impact, for papers by Veronica Fitzgerald
Rankless by CCL
2026